Casdin Capital’s Qiagen QGEN Stock Holding History

Casdin Capital’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-360,000	Closed	-$14.4M	–	45
2026 Q1	$14.4M	Buy	+360,000	New	+$17M	1.09%	19

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Casdin Capital's QGEN Position: Q2 2026 in Review

Casdin Capital sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 360,000 shares — an estimated $14.4M sold.

Casdin Capital first reported a position in QGEN in Q1 2026 and held it in 1 quarter. The position peaked at $14.4M in Q1 2026. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

Casdin Capital reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
Casdin Capital sold 360,000 Qiagen shares in Q2 2026, an estimated $14.4M.
Casdin Capital first reported a position in Qiagen in Q1 2026 and held it in 1 quarter.
Casdin Capital's Qiagen position peaked at $14.4M in Q1 2026.
336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Casdin Capital's 13F filing for Q2 2026, filed 14 Aug 2026.